Loading...

Loading...

Alfasigma Invests MX$100 Million to Expand OTC Business in Mexico
By MBN Staff - Tue, 06/10/2025 - 11:08
Alfasigma will invest MX$100 million to launch a new OTC business unit in Mexico, introducing three GI products this year.
https://mexicobusiness.news/tag/otc-products
More Health
Bayer Expands Lerma Plant to Strengthen Regional Production
By MBN Staff - Tue, 01/14/2025 - 15:53
Bayer is investing MX$1.1 billion in its Lerma plant to increase production capacity and strengthen its role in global markets.

Interdisciplinary Industry-Focused Legal Advice
By - Wed, 09/09/2015 - 16:31
Our strategic investment in interdisciplinary teams who handle highly specialized services, covering the whole life cycle of a drug or medical device.
Limiting Advertising of Miracle Products
By - Wed, 09/09/2015 - 16:20
“Miracle products,” promising everything, lack the clinical studies necessary to support their claims.
Solid Market for Generic Alimentary Supplements
By - Wed, 09/09/2015 - 16:17
“The advantage of working with the government is the quantities ordered by public institutions, often tenders of more than a million units”
OTC Market Exceeds Growth Predictions
By - Wed, 09/09/2015 - 16:15
An estimated 1,187 brands of OTC products were reported in 2012 to be on sale in Mexico, compared to 700 brands in 2007.
Savvy Strategies for a Fragmented Market
By - Wed, 09/09/2015 - 16:08
The Loeffler brand focuses on generics and veterinary, Russek on manufacture, and Farmacenter as a distributor for the health sector.
A Diversified Portfolio for Success
By - Wed, 09/09/2015 - 15:24
Aspen Labs has operated for 160 years, enjoying great success in many countries.
Advisory Services for an Evolving Marketplace
By - Wed, 09/09/2015 - 15:02
The pharmaceutical business comprises consulting and professional services, while it is a large division in other countries, it remains quite small
Generics Commanding the Pharmaceutical Market
By - Wed, 09/09/2015 - 12:22
Fifteen years ago, local manufacturers were distrusted by the general public and the medical community due to quality issues and safety concerns.